Evolution of the Average Target: Kinaxis Inc.

Evolution of the Target Price: Kinaxis Inc.

Changes in Analyst Recommendations: Kinaxis Inc.

2d7d8b7134a71e220be6d6d52b67815.Pl3T2-jB85vk9k21z45SFCU2bawhNaFJVGfXiqbMsvI.CzCLlICem8-NuCKEnuo3U2xFWukMRcctCyaz5fmihJ0JFIa524i3-aa9dQ~bcb7471b9bf6fef98f6e6704b3a62d0f
05-08 Canada research roundup-Aritzia, Knight Therapeutics, WSP Global RE
05-06 Kinaxis Price target Lowered to $200.00 at Stifel Canada Ahead of Q1 Report MT
05-06 Canada research roundup - Cameco, Ero Copper, Thomson Reuters RE
04-24 RBC Provides its Canadian Technology Q1/CY26 Preview MT
04-17 CIBC Lowers Price Target on Software and Services Stocks MT
03-27 Shopify, Constellation, Kinaxis, Descartes Among RBC's Best Canadian Technology Investment Ideas MT
01-26 RBC Lowers Price Target on Seven Technology Stocks MT
01-07 RBC Says "2026 May Bring a Rebound for Canadian Software Stocks" MT
12-15 CIBC's Top Picks For 2026 Software Sector MT
12-15 CIBC's Top Picks For 2026 Software Sector MT
12-15 Kinaxis Upgraded, CGI Downgraded at CIBC MT
12-01 RBC Says Shopify, Constellation, and Kinaxis "Most Compelling Investment Ideas" in its Canadian Technology Coverage Universe MT
25-10-24 RBC Capital Markets Says Q3 Earnings for Its Canadian Technology Coverage "Likely To Remain Bifurcated" MT
25-10-24 RBC Capital Markets Says Q3 Earrings for Its Canadian Technology Coverage "Likely To Remain Bifurcated" MT
25-08-08 CANADA RESEARCH ROUNDUP-Atkinsréalis, Bombardier, Kinaxis RE
25-05-09 BMO Keeps It Outperform Rating on Kinaxis Shares Following Q1 Results; Price Target Raised to C$225.00 MT
25-02-28 BMO Keeps Outperform on Kinaxis After Q4 Beat MT
24-10-21 CIBC Raises Price Target on Six Software and Services Companies MT
24-08-28 Kinaxis Down 11% As National Bank Says "Optics Are Bad" Around Leadership Changes; Bank Has Outperform Rating, C$225 Target On KXS MT
24-06-21 CGI and Kinaxis Downgraded to Neutral at CIBC MT
24-06-21 Kinaxis Maintained at Buy at Stifel GMP Following Company Presentations; Price Target Kept at C$215.00 MT
24-06-20 Kinaxis Rating, Price Target Maintained Despite Lack of Execution in Sales, Marketing MT
24-03-01 Kinaxis Kept at Outperform at BMO Following Q4 Results; Price Target Lowered to C$175.00 MT
23-06-22 Kinaxis Price Target Raised to $220 at RBC MT
22-10-27 Kinaxis Buy Rating Reiterated by Stifel GMP Ahead of Q3 Results; Price Target Maintained at C$235.00 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+22.66%
+60.93%
+14.51%
+12.26%
+28.48%
+141.56%
+41.03%
+13.37%
+16.13%
+43.91%
Average +39.48%
Weighted average by Cap. +42.21%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
125.61USD
Average target price
149.60USD
Spread / Average Target
+19.10%
High Price Target
185.28USD
Spread / Highest target
+47.50%
Low Price Target
140.00USD
Spread / Lowest Target
+11.46%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

RBC Capital Markets
CIBC World Markets
BMO Capital
Stifel GMP
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
125.61USD
Average target price
149.60USD
Spread / Average Target
+19.10%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KXS Stock
  4. Consensus Kinaxis Inc.